Skip to content
zameds

Nifedipine (Cipalat Retard, Cipalat Xr, Nifedipine Cipla Xr)

Nifedipine

Cipla Medpro (Pty) Ltd

S3

Registration

Applicant
Cipla Medpro (Pty) Ltd
Registrations
5
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Cipalat retard

EACH TABLET CONTAINS NIFEDIPINE 20,0 mg

Not listed32066032/7.1/0660RegisteredS3None
Cipalat xr 30

EACH TABLET CONTAINS NIFEDIPINE 30,0 mg

30Extended release tablets50061750/7.1/0617Approved 6 February 2026RegisteredS3PIPIL
Cipalat xr 60

EACH TABLET CONTAINS NIFEDIPINE 60,0 mg

60Extended release tablets50061850/7.1/0618Approved 6 February 2026RegisteredS3PIPIL
Nifedipine cipla xr 30

EACH TABLET CONTAINS NIFEDIPINE 30,0 mg

3050061950/7.1/0619RegisteredS3None
Nifedipine cipla xr 60

EACH TABLET CONTAINS NIFEDIPINE 60,0 mg

6050062050/7.1/0620RegisteredS3None

Regulatory status

Where S3 sits on the scale

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Nifedipine

  • S3: Nifedipine

    Consolidated Schedules 06 July 2026, line 4029

Pharmacological class: Vasodilators, hypotensive, antihypertensive medicines include other antihypertensive medicines e.g. ACE-inhibitors, ARBs, RAAS, etc] (class 7.1)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C17H18N2O6346.30 g/mol

Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

Drag to rotate. Structure from PubChem CID 4485.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

This medication's schedule (S3) has been verified from official SAHPRA documents with 90% confidence.

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles